CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-01-02 | DEL GUERCIO JOSEPH Director | Grant or award · Options to purchase shares of Common Stock | +45,000 | 491,364 | ||
| 2015-01-02 | McLoughlin Mark T Director | Grant or award · Options to purchase shares of Common Stock | +45,000 | 435,000 | ||
| 2015-01-02 | HOHNKE LYLE A Director | Grant or award · Options to purchase shares of Common Stock | +45,000 | 620,000 | ||
| 2015-01-02 | WINZER C ERIC Director | Grant or award · Options to purchase shares of Common Stock | +45,000 | 285,000 | ||
| 2015-01-02 | KEITH STEPHEN Director | Grant or award · Options to purchase shares of Common Stock | +45,000 | 285,000 | ||
| 2014-12-31 | Aldagen Holdings, LLC 10% owner | Sale | −100 | $0.35 | $35 | 12,571,745 |
| 2014-12-30 | Aldagen Holdings, LLC 10% owner | Sale | −1,200 | $0.35 | $420 | 13,205,065 |
| 2014-12-30 | Aldagen Holdings, LLC 10% owner | Sale | −299,900 | $0.35 | $105K | 12,571,845 |
| 2014-12-29 | Aldagen Holdings, LLC 10% owner | Sale | −100 | $0.35 | $35 | 12,871,745 |
| 2014-12-22 | Aldagen Holdings, LLC 10% owner | Sale | −10,300 | $0.37 | $4K | 12,871,845 |
| 2014-12-19 | Aldagen Holdings, LLC 10% owner | Sale | −97,150 | $0.35 | $34K | 12,882,145 |
| 2014-11-28 | Aldagen Holdings, LLC 10% owner | Sale | −2,850 | $0.35 | $998 | 12,979,295 |
| 2014-11-11 | Aldagen Holdings, LLC 10% owner | Other acquisition | +1,270,000 | $1.18 | $1.5M | 13,206,265 |
| 2014-10-06 | TOZER DEAN Chief Commercial Officer | Purchase | +33,300 | $0.36 | $12K | 200,000 |
| 2014-09-12 | TOZER DEAN Chief Commercial Officer | Purchase | +40,000 | $0.45 | $18K | 166,700 |
| 2014-08-29 | TOZER DEAN Chief Commercial Officer | Purchase | +40,000 | $0.35 | $14K | 126,700 |
| 2014-08-26 | SHALLCROSS STEVEN A Chief Financial Officer | Purchase | +27,500 | $0.38 | $10K | 79,500 |
| 2014-08-22 | TOZER DEAN Chief Commercial Officer | Purchase | +38,700 | $0.38 | $15K | 86,700 |
| 2014-08-20 | ROSENDALE MARTIN P Chief Executive Officer | Purchase | +25,000 | $0.40 | $10K | 229,149 |
| 2014-08-20 | TOZER DEAN Chief Commercial Officer | Purchase | +48,000 | $0.39 | $19K | 48,000 |
Page 9 of 17 · 326 trades